uridine triphosphate has been researched along with desoxycorticosterone in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fink, GD; Galligan, JJ; Hess, MC; Miller, SB | 1 |
| Matsumoto, T; Tostes, RC; Webb, RC | 1 |
2 other study(ies) available for uridine triphosphate and desoxycorticosterone
| Article | Year |
|---|---|
Differential localization of P2 receptor subtypes in mesenteric arteries and veins of normotensive and hypertensive rats.
Topics: Adenosine Triphosphate; Algorithms; Animals; Desoxycorticosterone; Hypertension; Immunohistochemistry; Male; Mesenteric Arteries; Mesenteric Veins; Rats; Rats, Sprague-Dawley; Receptors, Purinergic P2; Uridine Triphosphate; Vasoconstriction | 2001 |
Alterations in vasoconstrictor responses to the endothelium-derived contracting factor uridine adenosine tetraphosphate are region specific in DOCA-salt hypertensive rats.
Topics: Adenosine Triphosphate; Animals; Aorta, Thoracic; Arteries; Basilar Artery; Desoxycorticosterone; Dinucleoside Phosphates; Disease Models, Animal; Dose-Response Relationship, Drug; Endothelium, Vascular; Femoral Artery; Hypertension; Male; Mesenteric Arteries; Purinergic P2 Receptor Agonists; Rats; Rats, Wistar; Receptors, Purinergic P2; Sodium Chloride, Dietary; Uridine Diphosphate; Uridine Triphosphate; Vasoconstriction; Vasoconstrictor Agents | 2012 |